News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
353,625 Results
Type
Article (39979)
Company Profile (36)
Press Release (313604)
Multimedia
Podcasts (82)
Webinars (12)
Section
Business (117349)
Career Advice (566)
Deals (14989)
Drug Delivery (87)
Drug Development (40063)
Employer Resources (65)
FDA (6530)
Job Trends (7320)
News (164641)
Policy (11124)
Tag
2025 Best Places to Work (4)
2026 Best Places to Work (6)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (3)
40 Under 40 (2)
Academia (2604)
Academic (1)
Accelerated approval (34)
ADA (20)
Adcomms (14)
Allergies (102)
Alliances (32749)
ALS (170)
Alzheimer's disease (1152)
Antibody-drug conjugate (ADC) (416)
Approvals (7007)
Artificial intelligence (638)
ASCO (186)
Autoimmune disease (271)
Automation (53)
Bankruptcy (140)
Belgium (24)
Best Places to Work (6180)
BIO (62)
Biologics (65)
BIOSECURE Act (10)
Biosimilars (145)
BioSpace Insights (110)
Biotechnology (28)
Bispecific (38)
Bladder cancer (95)
Brain cancer (63)
Breast cancer (553)
Cancer (4188)
Cardiovascular disease (324)
Career advice (530)
Career pathing (29)
CAR-T (245)
CDC (37)
CDMO (142)
Celiac Disease (5)
Cell therapy (667)
Cervical cancer (33)
Clinical research (35456)
Collaboration (2063)
Commercialization (51)
Company closure (2)
Compensation (247)
Complete response letters (43)
COVID-19 (1802)
CRISPR (89)
CRO (9)
C-suite (1373)
Cystic fibrosis (87)
Data (5674)
Decentralized trials (4)
Denatured (40)
Depression (115)
Dermatology (102)
Diabetes (364)
Diagnostics (3820)
Digital health (42)
Diversity (10)
Diversity, equity & inclusion (20)
Drug discovery (324)
Drug pricing (76)
Drug shortages (10)
Duchenne muscular dystrophy (171)
Earnings (28715)
Editorial (36)
Employer branding (5)
Employer resources (68)
ESMO (214)
Events (45744)
Executive appointments (1070)
Eye disease (15)
FDA (8794)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (3)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1672)
Gene editing (173)
Generative AI (59)
Gene therapy (523)
GLP-1 (513)
Government (2091)
Grass and pollen (1)
Guidances (197)
Healthcare (10410)
Hematology (122)
HIV (74)
Huntington's disease (41)
Idiopathic pulmonary fibrosis (4)
IgA nephropathy (89)
Immunology and inflammation (193)
Immuno-oncology (98)
Indications (134)
Infectious disease (2045)
Inflammatory bowel disease (127)
Inflation Reduction Act (7)
Influenza (94)
Intellectual property (200)
Interviews (63)
IPO (6452)
IRA (21)
Job creations (1260)
Job search strategy (452)
JPM (33)
Kidney cancer (21)
Kidney disease (103)
Labor market (56)
Layoffs (188)
Leadership (25)
Legal (2018)
Licensing (89)
Liver cancer (59)
Longevity (31)
Lung cancer (534)
Lung diease (19)
Lymphoma (326)
Machine learning (50)
Management (27)
Manufacturing (957)
Marketing (23)
MASH (135)
Medical affairs (4)
Medical device (6741)
Medtech (6890)
Melanoma (127)
Mergers & acquisitions (9378)
Metabolic disorders (884)
Middle East (1)
mRNA (186)
Multiple sclerosis (157)
Multispecific (3)
NASH (9)
Netherlands (23)
Neurodegenerative disease (372)
Neuropsychiatric disorders (68)
Neuroscience (2385)
Neurotech (3)
NextGen: Class of 2026 (3843)
Non-profit (3097)
Now hiring (18)
Obesity (354)
Opinion (125)
Ovarian cancer (174)
Pain (158)
Pancreatic cancer (211)
Parkinson's disease (293)
Partnered (34)
Patents (340)
Patient advocacy (4)
Patient recruitment (459)
Patient selection (51)
Peanut (32)
People (43198)
Peptides (19)
Pharmaceutical (7)
Pharmacy benefit managers (11)
Phase 1 (11130)
Phase 2 (15895)
Phase 3 (11518)
Pipeline (7628)
Policy (157)
Postmarket research (1203)
Preclinical (4894)
Press Release (39)
Prostate cancer (219)
Psychedelics (35)
Radioligand (2)
Radiopharmaceuticals (275)
Rare diseases (775)
Real estate (2792)
Recruiting (35)
Regenerative medicine (21)
Regulatory (10257)
Reports (22)
Research institute (1851)
Resumes & cover letters (65)
Rett syndrome (36)
RNA editing (24)
RSV (30)
Saudi Arabia (1)
Schizophrenia (112)
Series A (328)
Series B (212)
Service/supplier (2)
Sickle cell disease (72)
Special edition (11)
Spinal muscular atrophy (93)
Sponsored (30)
Startups (2692)
Stem cells (3)
Stomach cancer (7)
Substance use disorders (11)
Supply chain (90)
Switzerland (16)
Tariffs (40)
Tax incentives (1)
The Weekly (40)
Vaccines (748)
Venture capital (123)
Weight loss (217)
Wet AMD (5)
Women's health (104)
Worklife (5)
Date
Today (59)
Last 7 days (375)
Last 30 days (1826)
Last 365 days (15979)
2026 (14652)
2025 (15077)
2024 (17223)
2023 (20261)
2022 (23784)
2021 (28124)
2020 (27158)
2019 (25256)
2018 (18948)
2017 (16776)
2016 (16315)
2015 (19153)
2014 (13996)
2013 (12127)
2012 (12394)
2011 (12640)
2010 (11119)
Location
Africa (448)
Alabama (61)
Alaska (6)
Arizona (179)
Arkansas (12)
Asia (23056)
Australia (4506)
California (7968)
Canada (2319)
China (1104)
Colorado (366)
Connecticut (346)
Delaware (326)
Europe (56959)
Florida (1142)
Georgia (300)
Hawaii (3)
Idaho (35)
Illinois (763)
India (81)
Indiana (329)
Iowa (18)
Japan (548)
Kansas (61)
Kentucky (37)
Louisiana (32)
Maine (77)
Maryland (1051)
Massachusetts (5368)
Michigan (203)
Minnesota (412)
Mississippi (8)
Missouri (98)
Montana (20)
Nebraska (8)
Nevada (121)
New Hampshire (39)
New Jersey (2108)
New Mexico (23)
New York (2003)
North Carolina (1189)
North Dakota (12)
Northern California (4179)
Ohio (273)
Oklahoma (23)
Oregon (28)
Pennsylvania (1491)
Puerto Rico (13)
Rhode Island (45)
South America (542)
South Carolina (54)
South Dakota (2)
Southern California (3134)
Tennessee (180)
Texas (1371)
United States (28196)
Utah (262)
Vermont (1)
Virginia (230)
Washington D.C. (34)
Washington State (690)
West Virginia (4)
Wisconsin (97)
Wyoming (2)
353,625 Results for "osage university partners".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
D-Wave Partners with University of Arkansas to Establish Quantum Supply Chain Initiative at the Sam M. Walton College of Business
October 5, 2026
·
5 min read
Press Releases
Sofinnova Partners Promotes Javier Nunez-Vicandi to Partner, Strengthening Its Digital Medicine Strategy
November 2, 2026
·
3 min read
Earnings
BMS drops Prothena-partnered neuro drug, sales outlook improves on a Q3 beat
In addition to canning an Orum-acquired blood cancer candidate last month, Bristol Myers Squibb cut a Prothena-partnered neuro asset in the third quarter. But with sales climbing 7%, the Big Pharma raised its full-year revenue forecast.
October 29, 2026
·
4 min read
·
Gabrielle Masson
antibody-drug conjugate (ADC)
ESMO 2026: Merck’s Kelun-partnered ADC hits the ‘Goldilocks zone,’ VP says
At the European Society for Medical Oncology meeting this weekend, Merck will showcase three late-stage trials of its Kelun-Biotech–partnered TROP2-directed antibody sac-TMT that VP of Chemistry Alan Northrup says gets the payload release “just right.”
October 22, 2026
·
5 min read
·
Heather McKenzie
Insights
More arms, more questions: The new challenge in multispecific drug design
As trispecifics, cell engagers and other complex formats multiply, drug developers are seeking discovery and engineering partners to help navigate an expanding universe of molecular possibilities.
October 19, 2026
·
5 min read
·
Jennifer C. Smith-Parker
Press Releases
GUERBET : Update on discussions with financial partners.
November 2, 2026
·
2 min read
Press Releases
Biosenta Highlights Independent University of Calgary Research Validating Tri-Filler(TM) Antimicrobial Technology
University of Calgary research demonstrates more than 200-fold improvement in antibacterial performance while Biosenta advances commercialization
July 21, 2026
·
5 min read
Press Releases
Vycellix to Provide Universal Cell Cancer Therapy Progress Reports at Upcoming Investor & Partnering Meetings
June 5, 2026
·
4 min read
Press Releases
Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Partner
September 10, 2026
·
3 min read
Press Releases
Alamar Biosciences Partners with Leading Research Universities to Launch National Initiative Advancing Blood-Based Biomarkers for Neurodegenerative Diseases
July 13, 2026
·
6 min read
1 of 35,363
Next